Versant Capital Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,497
Closed -$20.2K 2816
2026
Q1
$20.2K Buy
4,497
+4,260
+1,797% +$22.2K ﹤0.01% 1817
2025
Q4
$1.46K Buy
+237
New +$1.72K ﹤0.01% 2486
2025
Q3
Sell
-80
Closed -$425 2692
2025
Q2
$425 Sell
80
-105
-57% -$620 ﹤0.01% 2558
2025
Q1
$1.64K Sell
185
-1,199
-87% -$14.4K ﹤0.01% 2297
2024
Q4
$19K Buy
1,384
+415
+43% +$7.66K ﹤0.01% 1060
2024
Q3
$26.5K Hold
969
0.01% 694
2024
Q2
$23.7K Sell
969
-44
-4% -$965 0.01% 648
2024
Q1
$21.6K Hold
1,013
0.01% 484
2023
Q4
$19.4K Sell
1,013
-595
-37% -$10.3K 0.01% 508
2023
Q3
$25.8K Buy
1,608
+405
+34% +$7.71K 0.01% 403
2023
Q2
$27.9K Buy
1,203
+4
+0.3% +$87 0.01% 404
2023
Q1
$27.6K Buy
1,199
+47
+4% +$955 0.01% 395
2022
Q4
$16.7K Hold
1,152
0.01% 514
2022
Q3
$22K Sell
1,152
-28
-2% -$643 0.01% 402
2022
Q2
$21K Hold
1,180
0.01% 419
2022
Q1
$30K Sell
1,180
-98
-8% -$2.51K 0.01% 365
2021
Q4
$35K Sell
1,278
-34
-3% -$985 0.01% 321
2021
Q3
$42K Buy
1,312
+16
+1% +$531 0.01% 268
2021
Q2
$40K Buy
1,296
+9
+0.7% +$260 0.01% 281
2021
Q1
$39K Hold
1,287
0.01% 350
2020
Q4
$25K Sell
1,287
-140
-10% -$2.26K 0.01% 445
2020
Q3
$18K Buy
1,427
+808
+131% +$10.2K 0.01% 465
2020
Q2
$7K Sell
619
-1,174
-65% -$16.7K ﹤0.01% 745
2020
Q1
$25K Buy
1,793
+1,031
+135% +$21.8K 0.01% 307
2019
Q4
$20K Sell
762
-39
-5% -$1.07K 0.01% 469
2019
Q3
$22K Buy
801
+25
+3% +$728 0.01% 434
2019
Q2
$21K Sell
776
-233
-23% -$6.58K 0.01% 454
2019
Q1
$33K Sell
1,009
-246
-20% -$7.49K 0.01% 396
2018
Q4
$36K Sell
1,255
-44
-3% -$1.58K 0.02% 331
2018
Q3
$59K Sell
1,299
-412
-24% -$18.3K 0.02% 249
2018
Q2
$63K Sell
1,711
-191
-10% -$6.45K 0.03% 235
2018
Q1
$56K Sell
1,902
-223
-10% -$7.54K 0.02% 258
2017
Q4
$72K Hold
2,125
0.03% 217
2017
Q3
$76K Buy
2,125
+360
+20% +$10.3K 0.04% 179
2017
Q2
$45K Buy
1,765
+650
+58% +$13.8K 0.02% 277
2017
Q1
$21K Buy
+1,115
New +$19.8K 0.01% 560

Other funds holding MYGN